Firm

Francisco Proença de Carvalho Unveils New Law Firm: A Blend of Tradition, Innovation, and Team-Centric Strategy

by

Lisbon, Portugal – Francisco Proença de Carvalho, a former partner at Uría Menéndez, has inaugurated his own legal practice in Lisbon’s Amoreiras building, just four months after his departure was highlighted by Iberian Lawyer with the headline “Proença de Carvalho goes solo.” Far from embarking on this new journey alone, Francisco has assembled a robust team including six partners and seven associates, many of whom have been his colleagues since the early 2000s. This new team is not just sticking to old practices but pioneering in incorporating modern strategies in the realm of law. Their … Read more

Victory for Clean Air: Court Stands Firm on Comprehensive Smog Regulations Amidst Fuel Industry Pushback

by

In a landmark ruling, a federal court has upheld sweeping new regulations designed to reduce smog levels, despite fervent opposition from the fuel industry. The decision aims to enforce stricter emission controls on various sectors, particularly focusing on automotive and manufacturing industries known for their significant contributions to air pollution. The upheld regulations come as a response to increasing concerns over air quality in urban regions, and its impact on public health and the environment. These new measures have been praised by environmental groups as a crucial step towards cleaner air, though they have been … Read more

Investors Alert: Join Pacira BioSciences Class Action Lawsuit by March 14, 2025 – Legal Representation Available Through The Gross Law Firm for PCRX Shareholders

by

Investors in Pacira BioSciences, Inc. are facing critical financial concerns following allegations of securities fraud, prompting a class action lawsuit that demands immediate attention. With a deadline of March 14, 2025, for Pacira’s shareholders to contact The Gross Law Firm to discuss their legal options, time is of the essence for those impacted by the company’s recent stock performance issues. Pacira BioSciences, known for its non-opioid pain management drugs, has come under legal scrutiny after accusations surfaced that the company may have misled investors about its business and financial prospects. These allegations suggest that Pacira … Read more

Judge Approves Tempur Sealy’s $4 Billion Acquisition of Mattress Firm, Overruling FTC Concerns

by

HOUSTON — A significant development in the retail and mattress industry unfolded on Friday as a federal judge ruled in favor of Tempur Sealy International’s ambitious $4 billion acquisition of Mattress Firm. This decision came despite the Federal Trade Commission’s (FTC) efforts to block the merger, claiming it would be detrimental to consumers. The transaction, initially announced in May 2023, was slated for completion in the latter half of last year. However, the FTC’s intervention has delayed the process, arguing that the merger would restrict competition and limit consumer choices by controlling significant retail outlets … Read more